Prostatic Neoplasms

"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the PROSTATE.

Descriptor ID	D011471
MeSH Number(s)	C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
Concept/Terms	Prostatic Neoplasms Prostatic Neoplasms Prostate Neoplasms Neoplasms, Prostate Neoplasm, Prostate Prostate Neoplasm Neoplasms, Prostatic Neoplasm, Prostatic Prostatic Neoplasm Prostate Cancer Prostate Cancer Cancer, Prostate Cancers, Prostate Prostate Cancers Cancer of the Prostate Prostatic Cancer Cancer, Prostatic Cancers, Prostatic Prostatic Cancers Cancer of Prostate

Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Genital Neoplasms, Male [C04.588.945.440]
Prostatic Neoplasms [C04.588.945.440.770]
Male Urogenital Diseases [C12]
Genital Diseases, Male [C12.294]
Genital Neoplasms, Male [C12.294.260]
Prostatic Neoplasms [C12.294.260.750]
Prostatic Diseases [C12.294.565]
Prostatic Neoplasms [C12.294.565.625]
Urogenital Neoplasms [C12.758]
Genital Neoplasms, Male [C12.758.409]
Prostatic Neoplasms [C12.758.409.750]

Below are MeSH descriptors whose meaning is related to "Prostatic Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".

Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 239 publications over 30 distinct years, with a maximum of 19 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	1	0	1
1992	1	0	1
1993	1	0	1
1994	1	0	1
1995	5	0	5
1996	3	0	3
1997	9	0	9
1998	7	0	7
1999	1	3	4
2000	3	2	5
2001	6	0	6
2002	5	0	5
2003	8	1	9
2004	9	2	11
2005	12	1	13
2006	8	1	9
2007	17	2	19
2008	8	2	10
2009	16	0	16
2010	14	2	16
2011	11	0	11
2012	6	0	6
2013	15	1	16
2014	11	0	11
2015	12	0	12
2016	8	2	10
2017	5	0	5
2018	2	1	3
2019	6	0	6
2020	8	0	8

Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.

Lowrance WT, Breau RH, Chou R, Chapin BF, Crispino T, Dreicer R, Jarrard DF, Kibel AS, Morgan TM, Morgans AK, Oh WK, Resnick MJ, Zietman AL, Cookson MS. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2021 Jan; 205(1):14-21.

View in: PubMed
Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 08 20; 38(24):2798-2811.

View in: PubMed
Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B. Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020 06 04; 382(23):2187-2196.

View in: PubMed
Dawson NA, Zibelman M, Lindsay T, Feldman RA, Saul M, Gatalica Z, Korn WM, Heath EI. An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer. Mol Cancer Ther. 2020 06; 19(6):1373-1382.

View in: PubMed
Dupont WD, Breyer JP, Plummer WD, Chang SS, Cookson MS, Smith JA, Blue EE, Bamshad MJ, Smith JR. 8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer. Nat Commun. 2020 03 23; 11(1):1523.

View in: PubMed
Shore ND, Antonarakis ES, Cookson MS, Crawford ED, Morgans AK, Albala DM, Hafron J, Harris RG, Saltzstein D, Brown GA, Henderson J, Lowentritt B, Spier JM, Concepcion R. Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines. Prostate. 2020 05; 80(6):527-544.

View in: PubMed
Parker DC, Cookson MS. The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer. Investig Clin Urol. 2020 02; 61(Suppl 1):S3-S7.

View in: PubMed
Yari H, Gali H, Awasthi V. Nanoparticles for Targeting of Prostate Cancer. Curr Pharm Des. 2020; 26(42):5393-5413.

View in: PubMed
Wang X, Ramamurthy G, Shirke AA, Walker E, Mangadlao J, Wang Z, Wang Y, Shan L, Schluchter MD, Dong Z, Brady-Kalnay SM, Walker NK, Gargesha M, MacLennan G, Luo D, Sun R, Scott B, Roy D, Li J, Basilion JP. Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer. Cancer Res. 2020 01 15; 80(2):156-162.

View in: PubMed
Cookson MS. Urology perspective on the expanding world of germline testing for prostate cancer. Can J Urol. 2019 10; 26(5 Suppl 2):5-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals